| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 3, 2002
Accepted on November 27, 2002
From the Department of Biomedical Engineering (P.C., S.M.C., L.M.G.), the Center for Anesthesiology Research (D.S.D.), and the Departments of Vascular Surgery and Cardiovascular Medicine (L.M.G.), Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
* To whom correspondence should be addressed. E-mail: grahaml{at}ccf.org.
ObjectiveEndothelial cell (EC) migration, essential for reestablishing arterial integrity after vascular injury, is inhibited by oxidized LDL (oxLDL) and lysophosphatidylcholine (lysoPC) that are present in the arterial wall. We tested the hypothesis that 1 mechanism responsible for lysoPC-induced inhibition is increased intracellular free calcium concentration ([Ca2+]i).
Methods and ResultsLysoPC, at concentrations that inhibit in vitro EC migration to 35% of control, increased [Ca2+]i levels 3-fold. These effects of lysoPC were concentration dependent and reversible. LysoPC induced Ca2+ influx within 10 minutes, and [Ca2+]i remained elevated for 2 hours. The calcium ionophore A23187 also increased [Ca2+]i and inhibited EC migration. Chelators of intracellular Ca2+ (BAPTA/AM and EGTA/AM) and non-voltage-gated channel blockers (lanthanum chloride and gadolinium chloride) blunted the lysoPC-induced [Ca2+]i rise and partially preserved EC migration. After lysoPC treatment, calpain, a calcium-dependent cysteine protease, was activated, and cytoskeletal changes occurred. Calpain inhibitors (calpastatin, MDL28170, and calpeptin) added before lysoPC prevented cytoskeletal protein cleavage and preserved EC migration at 60% of control levels.
ConclusionsThese findings suggest that lysoPC increases [Ca2+]i, activating calpains that alter the cytoskeleton and inhibiting EC migration.
This article has been cited by other articles:
![]() |
P. Chaudhuri, S. M. Colles, M. Bhat, D. R. Van Wagoner, L. Birnbaumer, and L. M. Graham Elucidation of a TRPC6-TRPC5 Channel Cascade That Restricts Endothelial Cell Movement Mol. Biol. Cell, August 1, 2008; 19(8): 3203 - 3211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavi, J. P. McConnell, C. S. Rihal, A. Prasad, V. Mathew, L. O. Lerman, and A. Lerman Local Production of Lipoprotein-Associated Phospholipase A2 and Lysophosphatidylcholine in the Coronary Circulation: Association With Early Coronary Atherosclerosis and Endothelial Dysfunction in Humans Circulation, May 29, 2007; 115(21): 2715 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Farooqui and L. A. Horrocks Phospholipase A2-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly Neuroscientist, June 1, 2006; 12(3): 245 - 260. [Abstract] [PDF] |
||||
![]() |
N. Watanabe, J. W. Zmijewski, W. Takabe, M. Umezu-Goto, C. L. Goffe, A. Sekine, A. Landar, A. Watanabe, J. Aoki, H. Arai, et al. Activation of Mitogen-Activated Protein Kinases by Lysophosphatidylcholine-Induced Mitochondrial Reactive Oxygen Species Generation in Endothelial Cells Am. J. Pathol., May 1, 2006; 168(5): 1737 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Fearon OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production Cardiovasc Res, March 1, 2006; 69(4): 855 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Yang, J. P. McConnell, R. J. Lennon, G. W. Barsness, G. Pumper, S. J. Hartman, C. S. Rihal, L. O. Lerman, and A. Lerman Lipoprotein-Associated Phospholipase A2 Is an Independent Marker for Coronary Endothelial Dysfunction in Humans Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 106 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhuri, S. M. Colles, P. L. Fox, and L. M. Graham Protein Kinase C{delta}-Dependent Phosphorylation of Syndecan-4 Regulates Cell Migration Circ. Res., September 30, 2005; 97(7): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Satish, H. C. Blair, A. Glading, and A. Wells Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of {micro}-Calpain Mol. Cell. Biol., March 1, 2005; 25(5): 1922 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rebai, J. Le Petit-Thevenin, N. Bruneau, D. Lombardo, and A. Verine In Vitro Angiogenic Effects of Pancreatic Bile Salt-Dependent Lipase Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Glading, R. J. Bodnar, I. J. Reynolds, H. Shiraha, L. Satish, D. A. Potter, H. C. Blair, and A. Wells Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation Mol. Cell. Biol., March 15, 2004; 24(6): 2499 - 2512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, A. J. Ryan, J. Medh, and R. K. Mallampalli Oxidized Lipoproteins Inhibit Surfactant Phosphatidylcholine Synthesis via Calpain-mediated Cleavage of CTP:Phosphocholine Cytidylyltransferase J. Biol. Chem., September 26, 2003; 278(39): 37032 - 37040. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |